Clinical Trial

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Study acronym: AGAINST-PLD
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Multicenter trial on the effect of the GnRH analogue leuprorelin on the growth of total liver volume in pre-menopausal women with very severe polycystic liver disease who, despite available therapy, experience growth and are heading for liver transplantation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-07-27.
Trial Details
NCT Number NCT05478083
Lead Sponsor University Medical Center Groningen
Collaborators: Radboud University Medical Center
Conditions Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney
Enrollment 36 participants
Start Date 2022-06-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2022-11-04